Ganga Pharmaceuticals has informed that the meeting of the Board of Directors of the Company is scheduled on 05/11/2018, inter alia, to consider and approve the Unaudited Financial Results of the Company for the half year ended September 30, 2018.
The above information is a part of company’s filings submitted to BSE.